{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:20:18Z","timestamp":1773991218489,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3873-y","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T14:04:34Z","timestamp":1552917874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rubella outbreak in the school children, Addis Ababa, Ethiopia: February\u2013April 2018"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-9716","authenticated-orcid":false,"given":"Getachew","family":"Dinede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigiya","family":"Wondimagegnehu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikre","family":"Enquselassie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"3873_CR1","unstructured":"Fauci S, Kasper L, Hauser L, Harrison R. Principles of Internal Medicine: Rubella. 18th ed. USA: The McGraw-Hill Companies, Inc; 2012."},{"key":"3873_CR2","first-page":"1","volume":"14","author":"T Lanzieri","year":"2017","unstructured":"Lanzieri T, Redd S, Abernathy E, Icenogle J. Surveillance Manual. Rubella: Chapter. 2017;14:1.","journal-title":"Rubella: Chapter"},{"issue":"3","key":"3873_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.siny.2013.11.008","volume":"19","author":"V Kancherla","year":"2014","unstructured":"Kancherla V, Oakley GP, Brent RL. Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med. 2014;19(3):153\u201360.","journal-title":"Semin Fetal Neonatal Med"},{"key":"3873_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","volume":"2","author":"E Miller","year":"1982","unstructured":"Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781\u20134.","journal-title":"Lancet"},{"key":"3873_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(88)92249-0","volume":"1","author":"G Enders","year":"1988","unstructured":"Enders G, Miller E, Nickerl-Pacher U, Cradock-Watson JE. Outcome of confirmed periconceptual maternal rubella. Lancet. 1988;1:1445\u20137.","journal-title":"Lancet"},{"issue":"3","key":"3873_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/505944","volume":"43","author":"S Reef","year":"2006","unstructured":"Reef S, Redd S, Abernathy E, Zimmerman L, Icenogle J. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998\u20132004: the evidence for absence of endemic transmission. J Clin Infect Dis. 2006;43(3):126\u201332.","journal-title":"J Clin Infect Dis"},{"issue":"3","key":"3873_CR7","doi-asserted-by":"publisher","first-page":"e0149160","DOI":"10.1371\/journal.pone.0149160","volume":"11","author":"E Vynnycky","year":"2016","unstructured":"Vynnycky E, Adams EJ, Cutts FT, Reef SE, Navar AM, Simons E, et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review. PLoS One. 2016;11(3):e0149160.","journal-title":"PLoS One"},{"key":"3873_CR8","doi-asserted-by":"crossref","unstructured":"Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977;7(1):69\u201381. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/576606 .","DOI":"10.1007\/BF01531116"},{"key":"3873_CR9","doi-asserted-by":"crossref","unstructured":"World Health Organization. Rubella vaccines: WHO position Paper. Wkly Epidemiol Rec. 2011;86(29):301\u201316. https:\/\/www.who.int\/immunization\/policy\/position_papers\/rubella\/en\/ .","DOI":"10.1016\/j.vaccine.2011.08.061"},{"issue":"9984","key":"3873_CR10","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","volume":"385","author":"N Lambert","year":"2015","unstructured":"Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385(9984):2297\u2013307. https:\/\/doi.org\/10.1016\/S0140-6736(14)60539-0 .","journal-title":"Lancet"},{"key":"3873_CR11","unstructured":"Measles and Rubella Initiatives: Annual report; 2014."},{"key":"3873_CR12","doi-asserted-by":"publisher","unstructured":"Orenstein, W.A., Cairns, L., Hinman, A., Nkowane, B., Oliv\u00e9, J.M., Reingold, A.L., 2018. Measles and Rubella Global Strategic Plan 2012\u20132020 midterm review report: Background and summary. Vaccine, 36, pp. A35-A42. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.065 ; 2017.","DOI":"10.1016\/j.vaccine.2017.10.065"},{"key":"3873_CR13","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1186\/s12889-016-3841-z","volume":"16","author":"M Getahun","year":"2016","unstructured":"Getahun M, Beyene B, Gallagher K, Ademe A, Teshome B, Tefera M, et al. Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009\u20132015. BMC Public Health. 2016;16:1168. https:\/\/doi.org\/10.1186\/s12889-016-3841-z .","journal-title":"BMC Public Health"},{"key":"3873_CR14","unstructured":"Federal Democratic Republic of Ethiopia Central Statistical Agency. Population Projection of Ethiopia for All Regions At Wereda Level from 2014\u20132017, Addis Ababa, Ethiopia, 2013."},{"key":"3873_CR15","unstructured":"World Health Organization. African regional guidelines for measles and rubella surveillance. African Regional guidelines for measles and rubella surveillance- Draft version April 2015.WHO Regional Office for Africa. 2015."},{"key":"3873_CR16","doi-asserted-by":"publisher","unstructured":"Mitiku K, Bedada T, Masresha B, Kegne W, Nafo-Traore F, Tesfaye N, et al. The epidemiology of rubella disease in Ethiopia: Data from the measles case-based surveillance system. JID. 2011;204(Suppl 1). https:\/\/doi.org\/10.1093\/infdis\/jir120 .","DOI":"10.1093\/infdis\/jir120"},{"key":"3873_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12879-015-0989-6","volume":"15","author":"N Ian","year":"2015","unstructured":"Ian N, Dickens O, Yusuf A, Elizabeth K. Rubella outbreak in a rural Kenyan district, 2014: documenting the need for routine rubella immunization in Kenya. BMC Infect Dis. 2015;15:245.","journal-title":"BMC Infect Dis"},{"issue":"49","key":"3873_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2016.25.49.10003","volume":"25","author":"AO Semeeh","year":"2016","unstructured":"Semeeh AO, Henry CU. Incidence of rubella in a state in North-western Nigeria: a call for action. Pan Afr Med J. 2016;25(49):1\u20136. https:\/\/doi.org\/10.11604\/pamj.2016.25.49.10003 .","journal-title":"Pan Afr Med J"},{"key":"3873_CR19","unstructured":"The immunological basis for immunization series. Module 11: Rubella. Immunization, Vaccines and Biological. 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2008. http:\/\/whqlibdoc.who.int\/publications\/2008\/9789241596848_eng.pdf"},{"issue":"1","key":"3873_CR20","first-page":"1","volume":"1","author":"N Asamene","year":"2017","unstructured":"Asamene N, Abuboker R, Mihret A, Beyene D. Rubella outbreak investigation in Wombera and Dibate district, Metekel Zone, Benshangul Gumuz Region, January, 2013. Archives of Infect Diseases and Therapy. 2017;1(1):1\u20137.","journal-title":"Archives of Infect Diseases and Therapy"},{"key":"3873_CR21","unstructured":"World Health Organization. Global measles and rubella strategic plan: 2012\u20132020. ISBN 978 92 4 150339 6, NLM classification: WC 500;2012."},{"key":"3873_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2017.11.062","volume":"36","author":"AR Hinman","year":"2018","unstructured":"Hinman AR. Measles and rubella eradication. Vaccine. 2018;36:1\u20133. https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.062 .","journal-title":"Vaccine"},{"key":"3873_CR23","doi-asserted-by":"crossref","unstructured":"Leora RF, Stephanie M, Marta G, Mamadou SD, Laura MC, Aaron SW. Global Routine Vaccination Coverage, 2016. MMWR. 2017;66(45). http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/","DOI":"10.15585\/mmwr.mm6645a3"},{"issue":"42","key":"3873_CR24","first-page":"413","volume":"85","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Controlling rubella and preventing congenital rubella syndrome\u2014 global progress, 2009. Wkly Epidemiol Rec. 2010;85(42):413\u20137.","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"3873_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s12098-009-0124-z","volume":"76","author":"SN Gupta","year":"2009","unstructured":"Gupta SN, Gupta NN. An outbreak of rubella in a hilly district of Kangra-Chamba, Himachal Pradesh, India, 2006. Indian J Pediatr. 2009;76(7):717\u201323.","journal-title":"Indian J Pediatr"},{"key":"3873_CR26","unstructured":"Yuan L. Measles outbreak in 31 schools: Risk factors for vaccine failure and evaluation of a selective revaccination strategy. Can Med Assoc J. 1994;150(7)."},{"issue":"4","key":"3873_CR27","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/21645515.2016.1252494","volume":"13","author":"C Caiyu Chang","year":"2017","unstructured":"Caiyu Chang C, Ma H, Liang W, Pei H, Mo X, An Z, et al. Rubella outbreak and outbreak management in a school setting, China, 2014. Human vaccines and immunotherapeutics. 2017;13(4):772\u20135. https:\/\/doi.org\/10.1080\/21645515.2016.1252494 .","journal-title":"Human vaccines and immunotherapeutics"},{"key":"3873_CR28","unstructured":"Federal Negarit Gazette of the Federal Democratic Republic of Ethiopia. Ethiopian Public Health Institute Establishment Council of Ministers Regulation. Regulation no. 301\/2013. 20th Year No. 10. Addis Ababa, Ethiopia; 2014."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3873-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T23:13:59Z","timestamp":1663110839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3873"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3873-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"24 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research Ethical Review Committee of Addis Ababa Health Bureau approved the study. Permission to conduct the study was also obtained from Yeka sub-city health office. The national public health authority is empowered to conduct outbreak investigation as stated in Ethiopian Public Health Institute Establishment Council of Ministers Regulation No.301\/2013 [] to protect the community from outbreak impacts which compel communities to participate in the process as they are direct beneficiaries. The investigation was also exempted from ethical committee clearance based on this regulation. Confidential codes were used to protect individual privacy of our research participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable because data which could affect individual privacy was not indicated in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"267"}}